SCHEMBL2285221

SCHEMBL2285221

CCC=NC(=O)CCCCCCO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GPR84 Q9NQS5 2/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GAA P10253 1/20 0.34
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
SQLE Q14534 1/20 0.32
CES2 O00748 3/20 0.32
CES1 P23141 3/20 0.32
SLC22A6 Q4U2R8 1/20 0.31
SLC22A8 Q8TCC7 1/20 0.31
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2283686 0.82 PLA2G2A (0.33) GPR84FFAR1FFAR4ALDH1A1TSHR
SCHEMBL11038992 0.78 TERT (0.58) LMNAHSD17B10MEN1KMT2APPARG
SCHEMBL7835791 0.78 TERT (0.58) LMNAHSD17B10MEN1KMT2APPARG
SCHEMBL2287698 0.77 MAPT (0.47) SMN1; SMN2KDM4EFFAR1FFAR4ALDH1A1
SCHEMBL289854 0.76 CES2 (0.46) GPR84FFAR1FFAR4ALDH1A1TSHR
SCHEMBL5136587 0.72 TERT (0.50) LMNAHSD17B10MEN1KMT2APPARG
SCHEMBL2281093 0.72 ACHE (0.44) ALDH1A1LMNATSHRGAA
SCHEMBL471783 0.71 CES2 (0.45) GPR84FFAR1FFAR4ALDH1A1TSHR
SCHEMBL17115809 0.69 GPR84 (0.52) SMN1; SMN2KDM4EGPR84FFAR1FFAR4
SCHEMBL5185770 0.68 FAAH (0.50) KDM4EGPR84FFAR1FFAR4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994273-B2 Photoactive materials ROLIC AG (CH) 2011-08-09 US claimed
US-7750185-B2 Photoactive materials ROLIC AG (CH) 2010-07-06 US claimed
US-20050288480-A1 Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked ROLIC AG (CH) 2005-12-29 US claimed
EP-1525182-A1 PHOTOACTIVE MATERIALS Rolic AG (CH) 2005-04-27 EP claimed
WO-2004013086-A1 PHOTOACTIVE MATERIALS ROLIC AG (CH) 2004-02-12 WO claimed
EP-1386910-A1 Photoactive materials Rolic AG (CH) 2004-02-04 EP claimed
EP-1525182-B1 PHOTOACTIVE MATERIALS ROLIC AG (CH) 2016-04-06 EP disclosed
US-8436132-B2 Photoactive materials ROLIC AG (CH) 2013-05-07 US disclosed
US-20110236602-A1 PHOTOACTIVE MATERIALS ROLIC AG (CH) 2011-09-29 US disclosed
US-7994273-B2 Photoactive materials ROLIC AG (CH) 2011-08-09 US disclosed
US-20100272979-A1 PHOTOACTIVE MATERIALS ROLIC AG (CH) 2010-10-28 US disclosed
US-7750185-B2 Photoactive materials ROLIC AG (CH) 2010-07-06 US disclosed
US-20050288480-A1 Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked ROLIC AG (CH) 2005-12-29 US disclosed
EP-1386910-A1 Photoactive materials Rolic AG (CH) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110236602-A1 PHOTOACTIVE MATERIALS AOC1, CRY1, CCNA1 SMN1; SMN2 3592/4885KDM4E 3256/4885GPR84 3003/4885
US-20050288480-A1 Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked C9, F12, DAO SMN1; SMN2 4085/4885KDM4E 1781/4885GPR84 3503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.